Honored as one of the Top 10 Legal Innovators of the Year in Europe.Financial Times – European Innovative Lawyers Awards

Henning C. Schneider

  • Warburgstrasse 50
  • 20354 Hamburg
  • Germany

Dr. Henning C. Schneider is a partner in the Hamburg office of Latham & Watkins and Global Co-Chair of the firm’s Healthcare Services & Providers and Life Sciences Industry Groups. He is a member of several supervisory boards and President of the American Chamber of Commerce, Northern Chapter. Mr. Schneider is an alumnus of the German National Academic Foundation (Studienstiftung des Deutschen Volkes).

He focuses on advising international and national corporates, PE investors, and public organizations on:

  • M&A/PE transactions
  • Joint ventures, restructurings, carve-outs, and privatizations    

He offers broad industry expertise in healthcare/life sciences, financial services, infrastructure, automotive, real estate, and energy/cleantech.

JUVE lists Mr. Schneider as a recommended lawyer for M&A and Corporate Law. Clients are “very impressed.” He is also praised for his “excellent and timely advice” and as “highly competent, flexible, thinks strategically and has pronounced commercial understanding.”

Mr. Schneider led the team on Rhön-Klinikum’s €3 billion sale of major assets to Fresenius/Helios, which was honored by The Lawyer as European Corporate Deal of the Year. Financial Times European Lawyers Awards listed him as one of the Top 10 Legal Innovators of the Year in Europe and he is one of the best lawyers for Corporate/M&A in Germany (Handelsblatt Best Lawyers).

Chambers Europe Germany recognizes him as a key individual for M&A. Sources describe him as “very intelligent, with a good attitude in negotiations“ and clients appreciate that he is “very well connected within the healthcare arena and a helpful intermediary to other contacts in the industry, enjoying the trust of the main stakeholders;“ he is considered as “one of the most important advisers.” Clients praise that “he has a deep knowledge of corporate law, but also the mindset to understand clients’ commercial needs.” Furthermore, “he has a very deep knowledge of all questions of legal importance in a transaction – he concentrates on the sector, so you don’t have to start from zero when you work together.”

The Legal 500 mentions his “impressive presence in large transactions” praises the “high-profile team around Henning Schneider,” and names him “a heavyweight both in legal terms as well as in strategy.”

Mr. Schneider has published various articles in legal and business magazines and is the co-author of:

  • “Grabitz/Hilf/Nettesheim, Das Recht der Europäischen Union: EUV/AEUV,” C.H.Beck, 63rd edition, 2018
  • “Münchener Handbuch des Gesellschaftsrechts,” C.H.Beck, volumes 1 and 2, 4th/5h edition, 2017/2018

Dr. Schneider’s experience includes advising/representing:

  • Aurubis AG on its bid for several copper mines and smelters
  • Bankhaus Lampe (Oetker-Group) on the auction for the acquisition of BHF Bank from Deutsche Bank AG, and for the acquisition of LGT Bank
  • Bankhaus Lampe (Oetker-Group) on the sale of CEE Group to Brookfield Renewable Europe Asset Management GmbH
  • Berenberg Bank and Bankhaus Lampe on the sale of Universal-Investment, the fourth largest German investment company, to Montague
  • Capgemini on the acquisition of CS Consulting
  • Carlyle on the acquisition and the later sale of Alloheim Group
  • DAK Krankenkasse on the merger with BKK Gesundheit and on the merger with BKK Axel Springer
  • Delphi Automotive on the sale of Thermal Business to Mahle (US$700 million)
  • DPE Deutsche Private Equity on the acquisition of Zellbios Group
  • Dubai Ports/DP World on the €2.5 billion auction to acquire 49% in HHLA Hamburger Hafen und Logistik AG   
  • Freie und Hansestadt Hamburg on the privatization of its retirement and nursing homes
  • Hapag-Lloyd AG Konsortium on the €4.45 billion acquisition of Hapag-Lloyd AG from TUI AG
  • IK Investment Partners on the acquisition of SCHOCK Group
  • MAG Europe on restructuring and sale
  • Novo A/S on the investment in Evotec AG
  • Q-Cells SE on the sale to Hanwha Corporation, South Korea
  • Rhön-Klinikum AG on its sale of major assets (e.g. 40 hospitals) to Dax listed Fresenius (€3.14 billion) and on share buyback
  • Sana Kliniken AG on the acquisition of Regio Kliniken
  • Shareholders of Hanse Chemie AG/Nanoresins AG on the sale to Evonik AG
  • Siemens AG on several projects and transactions
  • Sparkasse Frankfurt, Sparkasse KölnBonn, and Sparkasse Düsseldorf on the sale of Corpus Sireo to Swiss Life
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.